The expression of CDKN2B-AS1 in BLM-induced pulmonary fibrosis mice was consistent with the results obtained in cells, with CDKN2B-AS1 gradually decreasing over time and reaching a low point at 14 d (Figure 1b). Here, CDKN2B is linked to pulmonary fibrosis.